Voya Investment Management LLC Praxis Precision Medicines, Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.8 - $4.98 $917 - $5,712	1,147 Added 6.35%	19,216 $15,000
Q4 2022 Feb 14, 2023	BUY	$1.88 - $2.49 $33,969 - $44,991	18,069 New	18,069 $43,000
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $21,941 - $142,180	-12,538 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $9,720 - $13,334	580 Added 4.85%	12,538 $247,000
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $157,247 - $269,772	11,958 New	11,958 $221,000

Q1 2021 May 17, 2021	SELL	$29.34 - $60.2 $116,157 - $238,331	-3,959 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.25 - $55.82 $107,882 - $220,991	3,959 New	3,959 $218,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $1.84B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.